Literature DB >> 11505164

Congenital heart defects, maternal febrile illness, and multivitamin use: a population-based study.

L D Botto1, M C Lynberg, J D Erickson.   

Abstract

We assessed the relation between febrile illness during pregnancy and cardiac defects in the offspring in a population-based case-control study in metropolitan Atlanta. Case infants (905) with cardiac defects were actively ascertained from multiple sources. Control infants (3,029) were infants without birth defects who were selected from birth certificates by stratified random sampling. We compared those whose mothers reported febrile illness from 1 month before pregnancy through the third month of pregnancy with those whose mothers reported no illness during the same period. Febrile illness was positively associated with the occurrence of heart defects in the offspring (odds ratio [OR] = 1.8; 95% confidence interval = 1.4-2.4). When influenzalike illness was the reported febrile illness, the OR was 2.1 (95% confidence interval = 0.8-5.5). The association with febrile illness was strongest for tricuspid atresia (OR = 5.2), left obstructive defects (OR = 2.7), transposition of the great arteries (OR = 1.9), and ventricular septal defects (OR = 1.8). These ORs were generally lower among mothers who used multivitamins during the periconceptional period.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11505164     DOI: 10.1097/00001648-200109000-00004

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  23 in total

1.  Risk factors of different congenital heart defects in Guangdong, China.

Authors:  Yanqiu Ou; Jinzhuang Mai; Jian Zhuang; Xiaoqing Liu; Yong Wu; Xiangmin Gao; Zhiqiang Nie; Yanji Qu; Jimei Chen; Christine Kielb; Ursula Lauper; Shao Lin
Journal:  Pediatr Res       Date:  2015-12-17       Impact factor: 3.756

Review 2.  Getting to the heart of the matter: epidemiology of cyanotic heart defects.

Authors:  Jennifer L Kornosky; Hamisu M Salihu
Journal:  Pediatr Cardiol       Date:  2008-01-10       Impact factor: 1.655

Review 3.  A review of isolated muscular ventricular septal defect.

Authors:  Toshiharu Miyake
Journal:  World J Pediatr       Date:  2019-07-25       Impact factor: 2.764

4.  Genetic counseling in the adult with congenital heart disease: what is the role?

Authors:  Luke Burchill; Steven Greenway; Candice K Silversides; Seema Mital
Journal:  Curr Cardiol Rep       Date:  2011-08       Impact factor: 2.931

5.  A parent-of-origin analysis of paternal genetic variants and increased risk of conotruncal heart defects.

Authors:  Wendy N Nembhard; Xinyu Tang; Jingyun Li; Stewart L MacLeod; Joseph Levy; Gerald B Schaefer; Charlotte A Hobbs
Journal:  Am J Med Genet A       Date:  2018-02-05       Impact factor: 2.802

Review 6.  Congenital heart defects and maternal fever: systematic review and meta-analysis.

Authors:  Q Y Shi; J B Zhang; Y Q Mi; Y Song; J Ma; Y L Zhang
Journal:  J Perinatol       Date:  2014-05-08       Impact factor: 2.521

7.  Analysis of selected maternal exposures and non-syndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005.

Authors:  Sonali S Patel; Trudy L Burns; Lorenzo D Botto; Tiffany J Riehle-Colarusso; Angela E Lin; Gary M Shaw; Paul A Romitti
Journal:  Am J Med Genet A       Date:  2012-08-17       Impact factor: 2.802

Review 8.  Maternal smoking during pregnancy and the risk of congenital heart defects in offspring: a systematic review and metaanalysis.

Authors:  Laura J Lee; Philip J Lupo
Journal:  Pediatr Cardiol       Date:  2012-08-12       Impact factor: 1.655

Review 9.  Primary prevention of neural-tube defects and some other congenital abnormalities by folic acid and multivitamins: history, missed opportunity and tasks.

Authors:  Andrew E Czeizel; Zoltán Bártfai; Ferenc Bánhidy
Journal:  Ther Adv Drug Saf       Date:  2011-08

Review 10.  Nongenetic risk factors and congenital heart defects.

Authors:  Sonali S Patel; Trudy L Burns
Journal:  Pediatr Cardiol       Date:  2013-08-21       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.